High-Content Kinetic Calcium Imaging in Drug-Sensitive and Drug-Resistant Human Breast Cancer Cells

Methods in Enzymology

Volumn 414, Issue , 2006, Pages 317-335

  DeBernardi, Maria A ^a   Brooker, Gary ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CAMPTOTHECIN; DOXORUBICIN; ETOPOSIDE; INOSITOL PHOSPHATE; MELPHALAN;

BREAST CANCER; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CANCER CELL CULTURE; CANCER THERAPY; CELL GROWTH; CELL LABELING; CELL TYPE; DATA ANALYSIS; DRUG SENSITIVITY; FLUORESCENCE MICROSCOPY; HUMAN; IMAGE ANALYSIS; IMAGING; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

EID: 33750835941     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)14018-5     Document Type: Chapter

References (36)

1. Bandyopadhyay A., Shin D.W., and Kim D.H. Regulation of ATP-induced calcium release in COS-7 cells by calcineurin. Biochem. J. 348 (2000) 173-181
2. Barrand M.A., Bagrij T., and Neo S.Y. Multidrug resistance-associated protein: A protein distinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen. Pharmacol. 28 (1997) 639-645
3. Berridge M.J., Bootman M.D., and Roderick H.L. Calcium signaling: Dynamics, homeostasis and remodelling. Nature Rev. Mol. Cell Biol. 47 (2003) 517-529
4. Chan G.K., Richards G.R., Peters M., and Simpson P.B. High content kinetic assay of neuronal signaling implemented on BD Pathway HT. ASSAY Drug Dev. Technol. 3 (2005) 623-636
5. Chen J.S.K., Agarwal N., and Mehta K. Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res. Treat. 71 (2002) 237-247
6. 2+/cAMP fluorescence ratio imaging. Proc. Natl. Acad. Sci. USA 93 (1996) 4577-4582
7. DeBernardi M.A., Hewitt S.M., and Kriete A. Automated confocal imaging and high-content screening for Cytomics. In: Pawley J.B. (Ed). "Handbook of Biological Confocal Microscopy" (2006), Springer Science, New York 818-828
8. Dickstein B., Valverius E.M., Wosikowsky K., Saceda M., Pearson J.W., Martin M.B., and Bates S.E. Increased epidermal growth factor receptor in an estrogen-responsive adriamycin-resistant MCF-7 cell line. J. Cell Physiol. 157 (1993) 110-118
9. DiVirgilio F., Steinberg T., and Silverstein S.C. Inhibition of Fura-2 sequestration and secretion with organic anion transport blockers. Cell Calcium 11 (1990) 57-62
10. Dixon C.J., Bowler W.B., Fleetwood P., Ginty A.F., Gallagher J.A., and Carron J.A. Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br. J. Cancer 75 (1997) 34-39
11. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 26 (1998) 15665-15670
12. Fairchild C.R., Ivy S.P., Kao-Shan C.S., Whang-Peng J., Rosen N., Israel M.A., Melera P.W., Cowan K.H., and Goldsmith M.E. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res. 47 (1987) 5141-5148
13. 2+ influx in HL-60 granylocytes. Cell Calcium 25 (1999) 69-76
14. Fujimori A., Gupta M., Hoki Y., and Pommier Y. Acquired camptothecin resistance in human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair. Mol. Pharmacol. 50 (1996) 1472-1478
15. Gollapudi S., Kim C.H., Tran B.N., Sangha S., and Gupta S. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpresssing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Cancer Chemother. Pharmacol. 40 (1997) 150-158
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
17. Hall J.G., Cory A.H., and Cory J.H. Lack of competition of substrates for P-glycoprotein in MCF-7 cells overexpressing MDR1. Adv. Enzyme Regul. 39 (1999) 113-128
18. Herman J.F., Mangala L.S., and Mehta K. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene (2006) Jan 30 Epub ahead of print
19. Homolya L., Hollo Z., Germann U., Pastan I., Gottesmann M.M., and Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268 (1993) 21493-21496
20. Kudoh K., Ramanna M., Ravatn R., Elkahloun A.G., Bittner M.L., Meltzer P.S., Trent J.M., Dalton W.S., and Chin KV. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res. 60 (2000) 4161-4166
21. Lee J.S., Scala S., Matsumoto Y., Dickstein B., Robey R., Zhan Z., Altenberg G., and Bates S.E. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J. Cell Biochem. 65 (1997) 513-526
22. i increase. J. Recept. Signal Transduct. Res. 17 (1997) 149-161
23. 2+ in drug-resistant ovarian epithelial cells. Exp. Physiol. 84 (1999) 285-297
24. Mestdagh N., Vandewalle B., Hornez L., and Henichart J.P. Comparative study of intracellular calcium and adenosine 3′,5′-cyclic monophosphate levels in human breast carcinoma cells sensitive and resistant to adriamycin: Contribution to reversion of chemoresistance. Biochem. Pharmacol. 48 (1994) 709-716
25. Moscow J.A., Swanson C.A., and Cowan K.H. Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan. Br. J. Cancer 68 (1993) 732-737
26. Ogretmen B., and Safa A.R. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax protein in multidrug-resistant MCF-7/Adr breast cancer cells. Int. J. Cancer 67 (1996) 608-614
27. Packham M.A., Rand M.L., Perry D.W., Ruben D.H., and Kinlough-Rathbone R.L. Probenecid inhibits platelet responses to aggregating agents in vitro and has a synergistic inhibitory effect with penicillin G. Thromb. Haemost. 76 (1996) 239-244
28. Padar S., van Breemen C., Thomas D.W., Uchizono J.A., Livesey J.C., and Rahimian R. Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its taxol-resistant subclone. Br. J. Pharmacol. 142 (2004) 305-316
29. Rahbar A.M., and Fenselau C. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells. J. Proteome Res. 4 (2005) 2148-2153
30. Schneider E., Horton J.K., Yang C.H., Nakagawa M., and Cowan K.H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity to topoisomerase II in breast carcinoma MCF-7 cells selected for etoposide resistance. Cancer Res. 54 (1994) 152-158
31. 2+-ATPases. Proc. Natl. Acad. Sci. USA 87 (1990) 2466-2470
32. Twentyman P.R., Reeve J.G., Koch G., and Wright K.A. Chemosensitization by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin). Br. J. Cancer 62 (1990) 89-95
33. Versantvoort C.H., Schuurhuis G.J., Pinedo H.M., Eekman C.A., Kuiper C.M., Lankelma J., and Broxterman H.J. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br. J. Cancer 68 (1993) 939-946
34. Vickers P.J., Dickson R.B., Shoemaker R., and Cowan K.H. A multidrug-resistant MCF-7 breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol. 2 (1988) 886-892
35. Villa A.M., and Doglia S.M. Mitochondria in tumor cells studied by laser scanning confocal microscopy. J. Biomed. Opt. 9 (2004) 385-394
36. Zhou Y., Xu Y., Qi J., Xiao Y., Yang C., Zhu Z., and Xiong D. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk. Res. 30 (2006) 469-476